Smoltek (Q3 Review): Setting the stage for 2027 - Redeye
Bildkälla: Stockfoto

Smoltek (Q3 Review): Setting the stage for 2027 - Redeye

Redeye comments on Smoltek’s Q3 2026 report, which was in line with our forecasts. Opex was slightly below our expectations, and both business areas continue to progress towards commercialisation. We leave our estimates essentially unchanged and keep our Base Case at SEK1.7.

Redeye comments on Smoltek’s Q3 2026 report, which was in line with our forecasts. Opex was slightly below our expectations, and both business areas continue to progress towards commercialisation. We leave our estimates essentially unchanged and keep our Base Case at SEK1.7.
Börsvärldens nyhetsbrev